Solentim, a developer of imagers for single cell cloning and tools for shortening the upstream cell line development workflow, has recently expanded its global sales reach to China by signing up two new distributors, Bio-reach Ltd., based in Beijing, and Dynamax Biotech Ltd., based in Shanghai.

"Having established ourselves with a strong base of customer sales and installations in the US and Europe over the past three years, China now represents a tremendous growth opportunity for us with Pharma, Biotech and CRO customers involved in developing cell lines for biologics and biosimilars, and also groups working on stem cells," commented Aaron Figg, Managing Director of Solentim.